Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/14/2024 | Q3 2024 | -$1.54 | $0 | |||
08/14/2024 | Q2 2024 | -$3.62 | $0 | |||
05/09/2024 | Q1 2024 | -$4.24 | $0 | |||
04/01/2024 | Q4 2023 | -$4.56 | $30,000 | |||
11/09/2023 | Q3 2023 | -$10.26 | $0 | |||
08/10/2023 | Q2 2023 | -$13.29 | $0 | |||
05/11/2023 | Q1 2023 | -$28.41 | $0 | |||
03/22/2023 | Q4 2022 | -$20.52 | $0 | |||
11/10/2022 | Q3 2022 | -$28.33 | $0 | |||
08/11/2022 | Q2 2022 | -$20.11 | $0 | |||
05/12/2022 | Q1 2022 | -$21.07 | $0 | |||
03/22/2022 | Q4 2021 | -$27.57 | $0 | |||
11/10/2021 | Q3 2021 | -$29.89 | $0 | |||
08/12/2021 | Q2 2021 | -$21.46 | $0 | |||
05/13/2021 | Q1 2021 | -$34.49 | $0 | |||
03/25/2021 | Q4 2020 | -$46.05 | $0 | |||
11/10/2020 | Q3 2020 | -$43.18 | $0 | |||
08/12/2020 | Q2 2020 | -$0.64 | -$36.40 | -35.76 | $0 | |
05/12/2020 | Q1 2020 | -$93.67 | $0 | |||
03/26/2020 | Q4 2019 | -$507.38 | $0 |
In the previous quarter, Phio Pharmaceuticals Corp. (:PHIOW) reported $-0.34 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64 by $0.3.
The conference call for Phio Pharmaceuticals Corp.'s latest earnings report can be listened to online.
The conference call transcript for Phio Pharmaceuticals Corp.'s latest earnings report can be read online.
Phio Pharmaceuticals Corp. (:PHIOW) has a recorded net income of $0. Phio Pharmaceuticals Corp. has generated $-46.87 earnings per share over the last four quarters.
Phio Pharmaceuticals Corp. (:PHIOW) has a price-to-earnings ratio of -0.48 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED